In Wednesday’s Wall Street session, Bicycle Therapeutics Plc ADR (NASDAQ:BCYC) shares traded at $7.41, down -3.01% from the previous session.
BCYC stock price is now -8.82% away from the 50-day moving average and -51.01% away from the 200-day moving average. The market capitalization of the company currently stands at $512.77M.
With the price target of $25, Stephens recently initiated with Equal-Weight rating for Bicycle Therapeutics Plc ADR (NASDAQ: BCYC). On September 06, 2024, RBC Capital Mkts recently initiated its ‘Outperform’ rating on the stock quoting a target price of $35, while ‘B. Riley Securities’ rates the stock as ‘Neutral’
In other news, Young Alethia, Chief Financial Officer sold 215 shares of the company’s stock on Apr 02 ’25. The stock was sold for $1,724 at an average price of $8.02. Upon completion of the transaction, the Chief Financial Officer now directly owns 45,390 shares in the company, valued at $0.34 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 03 ’25, CHIEF TECHNOLOGY OFFICER Skynner Michael sold 1,038 shares of the business’s stock. A total of $7,764 was realized by selling the stock at an average price of $7.48. This leaves the insider owning 121,870 shares of the company worth $0.9 million. A total of 11.18% of the company’s stock is owned by insiders.
During the past 12 months, Bicycle Therapeutics Plc ADR has had a low of $6.10 and a high of $28.67. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 14.86, and a quick ratio of 14.86. The fifty day moving average price for BCYC is $8.127 and a two-hundred day moving average price translates $15.12575 for the stock.
The latest earnings results from Bicycle Therapeutics Plc ADR (NASDAQ: BCYC) was released for 2025-03-31. The net profit margin was -790.02% and return on equity was -37.13% for BCYC. The company reported revenue of $9.98 million for the quarter, compared to $19.53 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -48.91 percent.